TMCI - TREACE ALERT: Bragar Eagel & Squire P.C. is Investigating Treace Medical Concepts Inc. on Behalf of Treace Stockholders and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, May 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI) on behalf of Treace stockholders. Our investigation concerns whether Treace has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On May 7, 2024, Treace issued a press release reporting its financial results for the first quarter of 2024. Among other items, Treace issued a "revise[d] guidance range for full-year 2024, expecting revenues of $201 million to $211 million from ...